As of 2025-04-19, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (65.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.03 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -1723.1%.
The range of the Relative Valuation is (57.80) - (78.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 16.3x | 14.0x |
| Forward P/E multiples | 10.5x - 16.6x | 13.2x |
| Fair Price | (57.80) - (78.35) | (65.41) |
| Upside | -1534.3% - -2044.1% | -1723.1% |
| Date | P/E |
| 2025-04-17 | -0.84 |
| 2025-04-16 | -0.88 |
| 2025-04-15 | -0.99 |
| 2025-04-14 | -0.96 |
| 2025-04-11 | -1.02 |
| 2025-04-10 | -0.86 |
| 2025-04-09 | -0.92 |
| 2025-04-08 | -0.89 |
| 2025-04-07 | -1.01 |
| 2025-04-04 | -1.02 |
| 2025-04-03 | -1.04 |
| 2025-04-02 | -1.14 |
| 2025-04-01 | -1.07 |
| 2025-03-31 | -1.31 |
| 2025-03-28 | -1.37 |
| 2025-03-27 | -1.39 |
| 2025-03-26 | -1.34 |
| 2025-03-25 | -1.33 |
| 2025-03-24 | -1.36 |
| 2025-03-21 | -1.30 |
| 2025-03-20 | -1.30 |
| 2025-03-19 | -1.27 |
| 2025-03-18 | -1.15 |
| 2025-03-17 | -1.01 |
| 2025-03-14 | -0.92 |
| 2025-03-13 | -0.88 |
| 2025-03-12 | -1.04 |
| 2025-03-11 | -1.00 |
| 2025-03-10 | -0.92 |
| 2025-03-07 | -1.05 |
| 2025-03-06 | -1.23 |
| 2025-03-05 | -1.27 |
| 2025-03-04 | -1.16 |
| 2025-03-03 | -1.09 |
| 2025-02-28 | -1.15 |
| 2025-02-27 | -1.20 |
| 2025-02-26 | -1.21 |
| 2025-02-25 | -1.16 |
| 2025-02-24 | -1.11 |
| 2025-02-21 | -1.18 |
| 2025-02-20 | -1.15 |
| 2025-02-19 | -1.20 |
| 2025-02-18 | -1.19 |
| 2025-02-14 | -1.20 |
| 2025-02-13 | -1.17 |
| 2025-02-12 | -1.14 |
| 2025-02-11 | -1.12 |
| 2025-02-10 | -1.13 |
| 2025-02-07 | -1.19 |
| 2025-02-06 | -1.23 |